Thank you Heather. Have you or are you participating in any trials? I am looking at a trial with both Nivolumab (Opdivo) and Ipilimumab (Yervoy) with the addition of a new agent called OX40. The idea is that the OX 40 will ramp up the T-cells and the Opdivo and Yervoy will remove the receptors that are blocking the T-cells in the tumor from doing their job.
I hope to start the trial in 2 weeks. If anyone else in participating in a clinical trial, please share your experience.
The GCS Project is dedicated to finding a cure for Gynecological Carcinosarcoma (aka MMMT), providing current scientifically valid information, and offering a place for the community impacted by this cancer to share stories and hope.